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Abstract: The availability of genome sequencing data in combination with knowledge of 
expressed genes via transcriptome and proteome data has greatly advanced our 
understanding of arthropod vectors of disease. Not only have we gained insight into vector 
biology, but also into their respective vector-pathogen interactions. By combining the 
strengths of postgenomic databases and reverse genetic approaches such as RNAi, the 
numbers of available drug and vaccine targets, as well as number of transgenes for 
subsequent transgenic or paratransgenic approaches, have expanded. These are now paving 
the way for in-field control strategies of vectors and their pathogens. Basic scientific 
questions, such as understanding the basic components of the vector RNAi machinery, is 
vital, as this allows for the transfer of basic RNAi machinery components into  
RNAi-deficient vectors, thereby expanding the genetic toolbox of these RNAi-deficient 
vectors and pathogens. In this review, we focus on the current knowledge of arthropod 
vector RNAi machinery and the impact of RNAi on understanding vector biology and 
vector-pathogen interactions for which vector genomic data is available on VectorBase.  
Keywords: RNA interference; vector; disease; mosquito; ixodid ticks; body louse; kissing 
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1. Introduction 
Vector-borne diseases are caused by pathogens that are transmitted between vertebrate hosts by 
another organism, predominantly via the saliva of blood-sucking arthropods, such as mosquitoes, fleas, 
lice, biting flies, mites and ticks. These may cause high incidences of morbidity, and in some instances 
mortality, not only affect low-income developing countries but also developed countries [1,2]. 
Biophysical, anthropogenic and climate changes affect vector population dynamics and disease 
transmission, as they influence the survival and reproduction rates of vectors. This in turn influences 
the distribution and abundance, habitat suitability, intensity and temporal pattern of vector activity 
throughout the year, and rates of development, survival and reproduction of pathogens within  
vectors [3]. As the severity of any vector-borne disease depends on the pathogen, the invertebrate 
vector and the human or animal host, understanding of the host-vector-pathogen interfaces is vital to 
gain insight into vector biology as well as pathogen survival and transmission. 
In this post-genomic era, scientists aim to obtain an integrative view of the host-vector-pathogen 
interfaces using studies that comprise genomics, transcriptome and proteome analyses, population 
biology and vector biology. In combination, this will expedite the development of novel  
therapeutics and vaccination alternatives and is already a major focus in research on mosquitoes [4], 
trypanosomes [5], tick-borne pathogens [6,7] as well as species-specific insecticides [8]. In 2006, 
VectorBase, a NIAID-funded Bioinformatic Resource Center, focused on invertebrate vectors of 
disease, was established online [9]. To date, it houses the genomes of Anopheles gambiae (vector for 
malaria), Aedes aegypti (vector for yellow fever and dengue fever), Culex pipiens (vector for 
lymphatic filariasis and West Nile fever), the body louse Pediculus humanus (vector for epidemic 
typhus), the triatomine Rhodnius prolixus (vector for Chagas disease), the tsetse fly Glossina morsitans 
(vector for sleeping sickness) and the tick Ixodes scapularis (vector for Lyme disease) 
(http://www.vectorbase.org). The availability of these YHFWRUV¶ genomic resources, in combination with 
completed genome sequences of a number of their associated pathogens (Table 1), has necessitated the 
development of annotation/ontology tools to describe vector processes that are involved in vector 
survival and disease transmission. As a result, researchers are now faced with annotation of a large 
number of genes with unknown functions [10].  
RNA interference, which refers to the silencing of the expression of a single gene, coupled with the 
resulting phenotype, has been used with great success in most of the abovementioned vectors for a 
growing understanding of function, as described in Section 2. The molecular mechanisms underlying 
the processes of dsRNA uptake, silencing, amplification and spreading of the silencing effect, as well 
as the proteins involved in these processes, however, remain to be clarified (Table 2). Based on RNAi 
methodology, the development of high-throughput genome-wide assay platforms for disease vectors is 
rapidly providing insight into host genes that are affected during pathogen infection. RNAi studies 
offers to facilitate gene annotation, unraveling the molecular interactions between vector-host and 
vector-pathogen and ultimately aiding in the discovery of novel vaccine and drug targets. 
In this review, we bring together the current knowledge on the RNAi machinery and mechanisms in 
vectors housed on VectorBase. In the first part, we focus on the progress made in terms of expanding 
our knowledge on invertebrate RNAi machinery and processes, followed by examples were RNAi has 
expanded our knowledge of the host-vector-pathogen interfaces. Finally, we highlight the current 
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status and future directions of RNAi and µRPLFV technology in controlling vectors and their  
associated pathogens. 
Table 1. Summary of vectors addressed in this review with their respective diseases, hosts 
and genomic summaries. Adapted from [11,12]. 




West Nile virus  
Wuchereria bancrofti  
West Nile Fever 
Lymphatic filariasis  
Genome (bp): 539,959,374 
Known protein-coding 
genes: 18,858 
Gene exons: 75,303  
Gene transcripts: 23,049 
Anopheles gambiae Plasmodium spp.  Malaria 
Genome (bp): 278,253,050 
Known protein-coding 
genes: 12,670 
Gene exons: 56,210 











Genome (bp): 1,310,090,344 
Known protein-coding 
genes: 15,704 
Gene exons: 66,827 
Gene transcripts: 18,769 
Ixodes scapularis 





Relapsing fever  
Base Pairs: 1,388,472,180 
Novel protein-coding genes: 
20,457 
Gene exons: 93,988 










Trench fever, endocarditis  
Louse-borne relapsing fever 
Base Pairs: 108,367,968 
Known protein-coding 
genes: 10,773 
Gene exons: 69,506 
Gene transcripts: 10,994 
Rhodnius prolixus 
(Kissing Bug) Trypanosoma cruzi Chagas Disease 
Base Pairs: 561,474,548 
Pseudogenes: 1,148 
Gene exons: 184,075 











Base Pairs: 363,107,930 
Gene exons: 64,464 
Gene transcripts: 12,362 
2. Invertebrate RNAi Machinery 
RNAi can be broadly defined as a class of processes that use short RNAs to regulate transcriptional 
and post-transcriptional gene regulation. Since the discovery of RNAi, numerous in vivo and in vitro 
studies have been performed to improve our understanding of the RNAi processes, and to  
identify the different components of the RNAi machinery of disease-causing organisms. From a 
combination of results, a widely conserved three step mechanistic model for RNAi has been derived 
(Figure 1) [13,14].  
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Table 2. Small RNA species and RNAi machinery described in vectors of disease and their 
associated transmitted pathogens. The human louse is not included as there is no current 



















Vector              
Tsetse fly 
(Glossinidae) Unexplored ND ND ND ND [15±17] 
Pathogen(s) 





RNase IIIa) TbAGO1, TbRIF5 Unknown Unknown [18±22] 
    
TbDLC2 
(nucleus, RNase 
IIIb)  TbRIF4, PIWI-tryp     
Vector              
Triatomine or kissing bugs (Triatome/ Reduviidae)  
Rhodnius 
prolixus Unexplored  ND ND ND ND [23] 
Triatomine 
brasiliensis Unexplored  ND ND ND ND [24] 
Pathogen(s) 
transmitted:   
Trypanosoma 
cruzi piRNA  Absent PIWI-tryp  Absent Absent [25] 
Vector             
Ixodid tick 
I. scapularis miRNA Drc-1 
Ago-1 (PIWI and 
PAZ domain) *Epn-1Cele Rsd-3 [26] 
  siRNA Ago-2 (PAZ) 
AP-50, Arf72, 
Clathrin hc, Rab7, 
CG3911, Cog3, 
IdICp   
Pathogen(s) 
transmitted:   
Babesia, 
Borrelia, 
Anaplasma Unexplored ND ND ND ND   
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Vector            
Mosquitoes       
Aedes aegypti / 
A .albopticus miRNA 
Drosha, Dicer-1 







  siRNA Dicer-2, R2D2 Ago-2 (VIG, TSN, Fmr-1) 
  piRNA Absent 
Ago-3, Ago-4 like (x 4), 




(Pasha, Loqs) Ago-1   
  siRNA Dicer-2, R2D2 Ago-2 (x 2) ( TSN, Fmr-1)   
  piRNA Absent 
Ago-3, Ago-4 like (x 3), 




(Pasha, Loqs) Ago-1   
  siRNA Dicer-2, R2D2 Ago-2 (Fmr-1)   
  piRNA Absent 
Ago-3, Ago-4 like, Ago-5 
like   
Pathogen(s) 
transmitted:   
Plasmodium  Absent Absent Absent Absent Absent [28,29] 
 
The first step in allowing non-cell-autonomous RNAi is the uptake of the dsRNA, followed by an 
RNAi initiating step. It involves the binding of an RNA-specific nuclease to a dsRNA fragment and its 
cleavage into smaller double stranded small RNAs, usually of either the interfering (siRNA, from 
exogenous long dsRNA precursors) or miRNA (triggered by endogenous stem-loop pre-miRNA) type. 
The third step involves the loading of the small dsRNAs into a multi-nuclease complex. Finally, within 
this protein complex, the guide RNA strand associates with a homologous mRNA strand by 
conventional base paring, and the mRNA strand is cleaved and released for further degradation within 
the cytoplasm (Figure 1).The recent comparative genomics studies between the processes of RNAi in 
different invertebrate organisms and model organisms such as D. melanogaster and C. elegans have 
provided evidence that, even though much of the basic RNAi machinery is evolutionary conserved, 
several components differ, indicating that the RNAi pathway may vary substantially between different 
arthropod classes [26]. 
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Figure 1. The RNAi process and biochemical machinery involved. Adapted from [30,31]. 
dsRNA is processed into short pieces (siRNA) by the endonuclease Dicer. The siRNA is 
loaded into the RNA-induced silencing complex (RISC) via the RISC loading complex 
(RLC), followed by cleavage and release of the passenger strand. The guide strand then 
associates with a homologous mRNA strand by conventional base paring, and the mRNA 
strand is cleaved by RISC and released for further degradation within the cytoplasm.  
 
Genes 2012, 3 708 
 
2.1. dsRNA Uptake  
Initiation of the RNAi pathway takes place once dsRNA is present within the cell [32]. In the case 
of artificially introduced exogenous dsRNA, two mechanisms of dsRNA uptake have been described 
in invertebrates: transmembrane channel-mediated uptake through orthologs of the multi 
transmembrane protein SID-1 (systemic RNA interference deficient-1) of C. elegans and an 
endocytosis-mediated uptake mechanism [33].  
SID-1 is a non-specific dsRNA transporter, engaged in the passive transport of dsRNA into cells 
and the spread of an RNAi response throughout an entire organism (systemic RNAi) [34,35]. This 
transporter protein is surface-expressed and displays diffusion-limited dsRNA transport that is energy 
independent. Recent evidence shows that SID-1 is instrumental in the import of silencing signals in  
C. elegans but not for export to neighboring tissues [36], and cells that are known to be refractory to 
gene silencing with exogenous dsRNA have been shown to be SID-1 deficient. Expression of SID-1 in 
these cells facilitated dsRNA uptake and subsequently an RNAi response [37]. While homologs of 
SID-1 have been reported in numerous organisms ranging from humans to various insects, they are 
noticeably absent from the genomes of others such as D. melanogaster, and this absence seems to 
correlate with a lack of a strong systemic RNAi response [34,38].  
Endocytosis as an uptake mechanism originated from the observation that D. melanogaster cells do 
not express SID-1 but are still able to internalize exogenous dsRNA. Studies of Drosophila S2 culture 
cells resulted in the identification of several factors necessary for dsRNA uptake, of which many are 
also implicated in endocytosis [39]. Owing to the fact that the RNAi response was weakened by 
blocking endocytosis via pharmaceutical agents, the role of endocytosis in RNAi is evident [40]. 
Uptake experiments with FITC-labeled dsRNA conducted by Saleh et al. (2006) also showed that 
dsRNA molecules associate with vesicles for receptor-mediated endocytosis, with components such as 
vacuolar H+ ATPases and scavenger proteins participating. It appears as if H+ ATPase plays a crucial 
role in catalyzing an endocytic pathway for successful RNAi induction. Two scavenger receptors, 
Eater (which mediates phagocytosis of bacterial pathogens) and Sr-CI (a scavenger receptor class C, 
type I protein) facilitate uptake of over 90% of the dsRNA in D. melanogaster [39], demonstrating that 
receptor-mediated endocytosis a major avenue. The involvement of endocytosis in the uptake of 
dsRNA in C. elegans is also apparent with various ³XSWDNH-JHQHV´ being involved. RSD3 (RNAi 
spreading defect 3) seems to be involved in uptake via its ENTH-domains (Epsin N-terminal 
homology domain), which have been linked to several intracellular trafficking events [33]. 
2.2. Initiation of RNAi  
The goal of the initiator step is to generate siRNAs from dsRNA. When exploiting RNAi as a 
reverse genetic tool, the process is artificially induced by the delivery of a dsRNA trigger. In  
non-mammalian systems long dsRNA (>200 bp) homologous to the target gene effectively triggers 
RNAi. In mammals, however, the introduction of dsRNA longer than 30 bp results in the activation of 
an anti-viral interferon response, which causes systemic non-specific inhibition of translation. 
Therefore in mammalian systems short synthetic siRNAs or DNA constructs, which express short 
hairpin RNAs (shRNAs), are typically used [41,42]. Since the specificity of RNAi depends  
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on the sequence and structure of the siRNAs [30], it is of great importance to carefully design the 
dsRNA or shRNA-constructs in order to maximize silencing of the target gene and ensure minimal  
off-target effects. 
The introduction of long dsRNAs into non-mammalian cells cause it to be processed into 21±25 nt 
double stranded RNAs (siRNAs), which have characteristic structures indicative of ribonuclease III 
(RNase III) cleavage [14,43,44]. Hannon and colleagues identified and demonstrated that the enzyme 
responsible for the initiation of RNAi in Drosophila is in fact an RNase III-like protein and owing to 
its biochemical function, named the enzyme Dicer [45,46]. Dicer acts as a monomer: the two 
ribonuclease III (RNase III) domains form a single processing center by assembling into a pseudo-dimer 
producing 2nt 3'-overhangs [47]. Dicer preferentially processes dsRNA from the ends of the substrates, 
with the Piwi/Argonaute/Zwille (PAZ) domain characterizing the 3'-overhangs [48±51] 
More profound insight into the structural mechanism used by Dicer came from the crystal structure 
of a Dicer protein derived from the protozoan Giardia intestinalis [52]. This structure revealed that 
Dicer attains an elongated shape and by this means acts as a molecular ruler, measuring the distance 
between the terminal-binding PAZ domain and the active site, thereby giving rise to the 21±25 nt 
products [52±54]. Although the structure and mechanism of G. intestinalis Dicer has been studied in 
detail, much less is known about Dicer proteins from higher eukaryotes [55]. Furthermore,  
G. intestinalis Dicer is an atypical Dicer in that it is much smaller and simpler than that found in any 
other organism to date, containing only the two RNase III domains and a PAZ domain. For example, 
human Dicer (219 kDa) is nearly three times larger than that of G. intestinalis (82 kDa). The difference 
in molecular mass is accounted for by at least five additional protein domains found in most Dicer 
proteins [55]. These include a TAR RNA-binding protein (TRBP) [56], an amino terminal DExD 
helicase-like domain [57], a putative dsRNA-binding domain (dsRBD) named DUF283 [58], an 
Argonaute-binding domain [59] and a C-terminal dsRBD [60]. These additional domains participate in 
dsRNA processing, regulate dicing activity and serve as molecular scaffolds for consolidating protein 
factors involved in the initiation of RNAi [55]. 
2.3. RNA-Induced Silencing Complex (RISC) Assembly 
Once a dsRNA trigger has been processed into siRNAs, the guide strand is identified and loaded 
into an effector ribonucleoprotein complex, the RNA-induced silencing complex (RISC). Since 
siRNAs cannot catalyze any reaction by themselves, RISC assembly is a key process for these small 
RNAs to exert their function [61]. To date, a complete understanding of the exact mechanism 
underlying this process remains elusive. Based on several in vitro studies of RISC assembly using  
D. melanogaster extracts and siRNAs as substrates, together with new structural studies of Argonaute 
(Ago), a revised 2-step model of the main features of this process has been proposed [62,63]. The first 
step, known as RISC-loading, involves the insertion of the siRNA duplexes into the Ago-protein. The 
second step entails the dissociation or unwinding of the passenger strand from RISC [61]. 
It is postulated that Dicer and a dsRNA binding partner (e.g. in D. melanogaster these are Dicer-2 
and R2D2) are bound to the double stranded siRNAs, to direct them to the RISC complex [64]. 
Current findings suggest that Dicer-2 and R2D2 form a heterodimer that binds the siRNA, with Dicer 
binding the thermodynamically less stable end of the siRNA and the dsRBD domain binding the more 
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stable end [61,65]. These thermodynamic and binding asymmetries appear to determine which strand 
is finally incorporated into RISC. The guide strand is always the strand whose ¶ end is less tightly 
paired to its complement, implying the strand with the least thermodynamically sTable 5¶ end [66,67]. 
Once the Dicer/dsRBD/siRNA ternary complex is formed it assembles with Ago-protein to form a 
RISC loading complex (RLC), which is an intermediate from which Dicer/dsRBD is gradually 
displaced by the Ago-protein to form pre-RISC [61,64,65,68,69]. Once bound to the siRNA duplex, 
Ago cleaves the passenger strand, triggering its dissociation [70]. After discharge of the passenger 
strand, possibly in an ATP-dependent step, the guide strand is in close association with Ago, forming a 
fully mature RISC, also referred to as siRISC [61,64,65,71]. 
2.4. Slicing or Silencing Steps 
In D. melanogaster, several RISC components have been identified, but only a few have been 
characterized at the functional level [72]. From current findings it is evident that RISC consists of 
several proteins and RNA molecules that act as key actors of RNAi promoting mRNA degradation, 
repression of translation and remodeling of chromatin structure [73]. The central catalytic component 
of RISC, Argonaute 2, was the first to be identified [74]. Argonaute proteins are characterized by two 
conserved domains: the PAZ (also present in Dicer) and PIWI domains [75]. Based on a higher degree 
of homology to either Arabidopsis AGO-1 or Drosophila PIWI, this family of proteins is subdivided 
into two highly conserved subclasses [76]. Recently an additional subclass, C. elegans-specific group 3 
Argonautes, has been identified [77]. Other components which have been identified as part of the 
RISC-complex include the Vasa intronic gene (VIG)-RNA binding protein, helicase proteins,  
Tudor- staphylococcal nuclease (Tudor-SN) and Fragile X -protein (dFXR) homologs [78,79]. To date 
most of these proteins remain functionally uncharacterized, however. Due to the lack of structural data, 
the exact catalytic mechanism of target mRNA cleavage remains unclear.  
In the RISC complex the ¶ end of the siRNA guide strand is bound by the PAZ domain, while the 
PIWI domain contacts the ¶ phosphorylated end [49,50]. Structural studies of prokaryotic Ago-like 
protein in complex with siRNA-mimics demonstrated that the sugar-phosphate backbone of the ¶ end 
of the guide strand (nucleotide 2 to 8) contacts the PIWI domain in such a manner that bases 2 to 8 are 
presented on the surface [80,81]. This region is known as the µVHHG¶ region [14]. Corresponding 
mRNA targets are initially bound by the seed region of the siRNA and then pairing is extended to the 
¶ end. A single cleavage of the target mRNA occurs across from nucleotide 10 and 11 (with respect to 
the ¶ end) of the guide stand. The catalytic engine is an RNaseH fold present in the PIWI  
domain [75,81,82]. Although target cleavage by Argonaute does not require ATP per se, release of the 
cleaved target (RISC recycling) is stimulated by ATP [83,84]. From in vivo studies it is evident that, 
once released from RISC, the ¶ mRNA fragment is degraded in the cytoplasm by exonuclease Xrn1, 
while the ¶ fragment is degraded by a complex of exonucleases, the so-called exosome [85]. In the 
RNAi pathway, siRISC operates as a multiple turn-over enzyme. Once the mRNA target is cleaved, 
siRISC dissociates from the cleaved mRNA to repeat another cleavage cycle [30]. 
In plant and nematode species it has been described that the RNAi signal is amplified by an  
RNA-dependent RNA polymerase (RdRP), which results in a systemic RNAi effect that can spread 
from the targeted/treated tissue to other tissues [86]. To date, this RdRP-dependent RNAi 
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amplification seems absent in higher eukaryotes, and even from D. melanogaster and mosquitoes. 
However, based on several RNAi studies in ticks it is evident that this phenomenon does occur in 
ticks, since application of dsRNA (via body cavity injection, feeding or soaking) results in global and 
persistent gene silencing in both treated ticks and their progeny [87±90]. Recent preliminary studies 
have indicated that this systemic RNAi effect in ticks is most likely attributed to a tick RdRP  
homolog [26].  
In order for RNAi to spread from one cell to another a transport system is required. In C. elegans 
several proteins, necessary for systemic RNAi have been identified. These include a multi 
transmembrane protein SID-1 (systemic RNA interference deficient-1(sid-1)) thought to act  
as a channel for dsRNA uptake [34], as well as RNAi spreading defective proteins (RSD2, RSD3, 
RSD6) [91]. To date only RSD3 and Endocytic protein (Epn-1) have been identified in ticks, leaving 
the mechanism of cell to cell dsRNA transport in ticks unresolved. Although more components of the 
tick RNAi machinery have been identified, the exact mechanism remains to be determined [26]. The 
current model for most invertebrate parasites RNAi is based on integrated knowledge of the RNAi 
process of model/other organisms including, D. melanogaster, C. elegans and mosquitoes (Figure 2).  
2.5. Transitive Amplification of the Initial dsRNA Signal 
In various plant and nematode species it has been found that the silencing signal is amplified by a 
process reliant on a RNA-dependent RNA polymerase (RdRP), which in effect permits a systemic 
RNAi response from the site of origin to eventually most or all other tissues [26,86]. A two-step 
mechanism has been described for RdRP amplification in C. elegans [92]. Once the primary siRNA 
has been generated by Dicer, RdRP uses the guide siRNA strand as primer and native mRNA as 
template to synthesize abundant secondary siRNAs and increasing the effectiveness of RNAi  
(Figure 2). As RNA synthesis occurs in a 5'±3' direction, this amplification leads to the 5' spreading of 
the initial RNA interference signal. This phenomenon is known as transitive RNAi [92].  
To date RdRP-dependent RNAi amplification seems absent in D. melanogaster, many other insects 
and higher eukaryotes. Interestingly, a putative homolog of the RdRP EGO-1 protein from C. elegans 
has also been identified in the tick species I. scapularis. This protein is associated with the 
amplification of trigger RNA by transcribing additional dsRNA molecules using target mRNA as a 
template, thereby yielding secondary siRNAs and increasing the effectiveness of RNAi [40,93]. RdRPs 
appear to be absent in other metazoans except for several nematodes and a lancelet (Branchiostoma 
floridae) [94]. The tick RNAi pathway may therefore differ from that of other arthropods, but more 
research is required to clarify the exact RNAi mechanism. 
2.6. Systemic RNAi 
In order for RNAi to spread from one cell to another a transport system is required. The 
phenomenon of the progression of an RNAi response from the site of origin to neighboring cells and 
eventually to all, or most, tissues of the organism was first described in plants and C. elegans . The 
systemic response may even persist through multiple developmental stages, including being transferred 
through the germline to the progeny. It has been proposed that this response has evolved as a strategy 
to increase the silencing efficiency [95] and it is known to form part of the immune system in plants. 
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For the functioning of a robust systemic response there are three essential steps: firstly the uptake of an 
extracellular dsRNA signal into a cell, secondly the amplification and distribution of the said signal to 
other cells, followed by a successful degradation or blocking of a homologous mRNA transcript [38]. 
Figure 2. A schematic representation of a putative RNAi pathway for invertebrate 
pathogens and vectors. The proposed model might either use a multi trans-membrane 
protein (similar to SID-1) for dsRNA uptake or an endocytosis-mediated process which 
may include scavenger receptors. Once the dsRNA is in the cytoplasma it is processed into 
siRNAs ~ 21±23 nt in length, by a Dicer homologue. The siRNA are then presented to 
RISC which incorporates the siRNA, targets and degrades any homologous mRNA. RISC 
includes Ago, TudorSN and FmRp homologues. The proposed activity of RdRP is 
indicated as amplifying either trigger dsRNA, cleaved siRNA or using primary siRNA to 
prime synthesis of secondary siRNAs utilizing native mRNA as template. This causes ¶ 
amplification and spreading of the initial RNAi signal, and is known as transitive RNAi.  
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Although the exact mechanisms pertaining to a systemic RNAi response remain unclear, many 
benefits associated with its presence makes it a highly desirable feature in organisms investigated 
using RNAi. Firstly, the amplification of the introduced RNAi signal means that lesser/smaller 
amounts of dsRNA can evoke the needed response throughout the entire organism. Secondly, the fact 
that silencing is spread and effected throughout all tissues makes target gene selection of the whole 
genome of the studied organism possible. This is especially relevant in those experiments where the 
mode of administering dsRNA cannot deliver it to all tissues, for example through oral delivery or 
direct injection. Another application made possible is the study of genes in life stages such as eggs that 
may not be amenable to other methods of dsRNA delivery. By delivering the relevant dsRNA to a 
preceding life stage, in this case the adult female, systemic RNAi will propagate the necessary signal 
throughout the adult as well as within any eggs produced by that female [88]. This application is 
known as parental, trans-stadial or transovarial RNA interference. Exploiting systemic RNA 
interference during RNAi studies is also a relatively simple procedure. For these reasons there is a 
definite advantage and incentive to elucidate the complete mechanism of systemic RNAi so that it 
could be induced experimentally in organisms that do not show a systemic RNAi response themselves. 
Although more pieces of the RNAi machinery of different disease vectors and pathogens have been 
identified, the exact mechanism of each remains unknown. Current RNAi models for most invertebrate 
parasites is based on integrated knowledge of the RNAi process of model/other organisms including  
D. melanogaster, C. elegans (Figure 2).  
3. RNAi of Lice, Ticks and Tick-Borne Pathogens 
3.1. RNAi Pathways and Methodologies  
Apart from model organisms such as Drosophila, ticks have provided us with a significant 
understanding of RNAi in arthropod vectors of disease and hence will be discussed in a bit more detail 
in this section. Ticks are obligate hematophagous parasites and are important vectors of a wide variety 
of pathogens including viruses, protozoa and bacteria which affect human and animal health 
worldwide [96]. Elucidating tick-host-pathogen interactions is of interest for the development of novel 
intervention strategies such as anti-tick and pathogen-transmission blocking vaccines to limit the 
damage caused by ticks and prevent the spread of pathogens. The increasing availability of genomic 
data from tick-borne pathogens and ticks such as Ixodes scapularis and Rhipicephalus (Boophilus) 
microplus has introduced a new era in tick research and greatly advanced studies addressing tick 
biology and host-vector-pathogen interactions [97±99]. The possibility to silence the expression of 
genes in ticks using RNA interference (RNAi) has proven to be pivotal in numerous studies which 
focus on deciphering tick gene function. Since the first report of an RNAi experiment in Amblyomma 
americanum ticks in 2002 [100], this method has been applied successfully in other hard ticks 
belonging to the Amblyomma, Dermacentor, Haemaphysalis, Ixodes, and Rhipicephalus genera and in 
Ornithodoros soft ticks [101±103]. 
Mites belong to the same subclass as ticks (Acari) and may also act as vectors of disease, albeit to a 
lesser extent. The most important mite-borne disease of humans is scrub typhus (Orientia 
tsutsugamushi), which is primarily transmitted by several members of the genus Leptotrombidium. 
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Parasitic mites living on or burrowing in the skin may also cause dermatitis in humans and animals. 
The full genome of the two-spotted spider mite Tetranychus urticae, a plant-feeding mite,  
was recently published and is the first chelicerate genome to be completely sequenced [104].  
Successful gene silencing by RNAi has also been described for this mite and the honey bee mite  
Varroa destructor [105,106]. 
Two mechanisms of dsRNA uptake have been described in arthropods: a transmembrane  
channel-mediated uptake through orthologs of the SID-1 protein of C. elegans and an  
endocytosis-mediated uptake [33]. As SID-1 is not present in tick and mite genome sequence 
databases, an endocytosis-mediated uptake is hypothesized in Acari. In the endocytosis-mediated 
uptake of dsRNA in Drosophila, scavenger receptors are thought to mediate dsRNA uptake [39,40]. 
Evidence for an endocytosis mediated mechanism for dsRNA uptake with an essential role for a 
scavenger receptor in ticks was recently provided by an µ51$L of 51$L¶ approach. When the 
expression of HlSRB, the class B scavenger receptor CD36 from Haemaphysalis longicornis, was 
silenced 96h before dsRNA coding for a second target gene (HlVg-1 or HlVgR, encoding vitellogenin 
and vitellogenin receptor) was introduced, subsequent knockdown of the second gene was inhibited. A 
double knockdown of target genes could however be observed when HlSRB was silenced 96h after the 
knockdown of HlVg-1 or HlVgR [93]. This suggests that receptor-mediated endocytosis is also relevant 
for systemic RNAi in ticks, with an essential role for scavenger receptor class B. Orthologs of the class 
B scavenger receptor CD36 within the superorder Parasitiformes have been annotated for I. scapularis 
(GenBank Accession number XP002409323) and the western predatory mite Metaseiulus occidentalis 
(XP003743396). Other key components of intracellular RNAi were recently identified from tick and 
mite genomic sequence databases by homology searches [26,104]. These include putative Dicers 
responsible for the cleavage of dsRNA to siRNAs, Argonaute proteins which function as the catalytic 
component of RISC and others (Table 2).  
RNAi is usually accomplished by treatment of ticks, tick tissues, tick cells or mites with  
dsRNA, but the successful use of siRNA to silence gene expression in these specimens has also been  
reported [106±109]. Most laboratories transcribe dsRNA in vitro from a PCR template which has been 
amplified using primers containing a T7 promoter sequence. The relative simplicity of synthesizing 
dsRNA and its high efficacy have made it the most commonly used mediator in tick RNAi studies. A 
drawback of the use of long dsRNA is that it increases the chance of causing off-target effects (OTE), 
leading to false discovery. OTE are caused by species-specific recognition of transcripts other than the 
intended target. This can be addressed in the experimental design by preventing the use of dsRNA 
sequences of which nucleotide stretches may recognize non-target transcripts. Various in silico 
prediction algorithms to analyze possible OTE have been described [110,111] but their application in 
tick research is frustrated by the absence of full tick genome data. The use of siRNA, small dsRNA 
(100±200 bp) or of two non-overlapping dsRNAs per gene to assess whether both induce the same 
phenotype, may limit the occurrence or facilitate the detection of OTE [110,112]. However, these 
strategies have thus far found only limited adaptation in tick research using RNAi. 
The injection of dsRNA into the hemacoel via the ventral exoskeleton surface using fine-gauge or 
pulled capillary needles is the most commonly used delivery method for dsRNA in ticks. After a 
recovery period to monitor for tick mortality resulting from the injection, ticks are fed on experimental 
animals or an artificial feeding system [100,113]. Parameters such as tick mortality, tick weight after 
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feeding and the amount of eggs oviposited can subsequently be recorded to evaluate the effect of  
gene silencing on general tick function. Biological material such as hemolymph or saliva and  
tissues can furthermore be collected for further analysis in functional assays and histological 
examination [114±117]. By injecting dsRNA into the hemocoel of freshly engorged female ticks 
through the spiracular plate, gene silencing can be established in the eggs and larvae hatching from 
these eggs [88,118,119]. A similar method can be used to silence genes in the eggs of mites [106]. The 
spread of dsRNA to different tissues following injection in the hemacoel demonstrates that RNAi is 
systemic in the Acari lineage.  
Infection of the I. scapularis cell line ISE6 with the a recombinant Semliki Forest Virus replicon 
expressing heterologous Nairovirus sequences induced siRNAs which inhibited the replication of 
Hazara virus, a Nairovirus, by RNAi in this cell line [120]. Besides this viral delivery, the incubation 
with dsRNA or siRNA is also effective in establishing gene silencing by RNAi in tick cells. Optimum 
conditions were however shown to vary for different cell lines. DsRNA was more efficient for gene 
silencing by RNAi in tick cells than siRNA and use of the latter requires a transfection reagent [121]. 
RNAi can also be used to study the effects of gene silencing on tissue function ex vivo following the 
immersion of dissected tissues in a dsRNA solution [113,122,123]. Overnight soaking at 4 °C in a 
0.9% saline solution containing dsRNA at a concentration of 2,5 µg/µL has been applied successfully 
to establish gene silencing in whole Varroa destructor mites. The addition of NaCl was apparently 
necessary as soaking in plain water containing dsRNA was not effective [105]. The soaking of whole 
ticks, which would reduce the laboriousness and mortality associated with injections and  
simplify dsRNA delivery especially in juvenile tick stages, has also been reported for  
Haemaphysalis longicornis nymphs but requires further optimization [124]. Soaking of eggs and 
nymphs in combination with electroporation was successfully used for dsRNA delivery in I. scapularis  
ticks [125].  
Further evidence for the occurrence of systemic RNAi in ticks was provided by Soares et al., who 
delivered dsRNA to I. scapularis nymphs using capillary feeding of a dsRNA solution. Ingested 
dsRNA targeting an anticomplement gene (isac) in the salivary gland spread via the gut to the target 
organ, where it resulted in a knockdown of isac expression [89].  
3.2. RNAi to Understand Tick Vector Biology 
RNAi has also helped to unravel the molecular complexity of tick physiology and biology. Hard 
ticks for example concentrate their blood meal during feeding by secreting excess water imbibed with 
the blood back into the host with saliva. A water channel or aquaporin (AQP) was found to be 
expressed in the gut and salivary glands, organs which are associated with a high water flux. Gene 
silencing of AQP in I. ricinus females by RNAi disrupted the water passage from gut to salivary 
glands, resulting in an accumulation of blood in the gut which could not be concentrated. The gut 
subsequently became too full to accommodate more blood and the total blood volume ingested was 
significantly reduced. The hemolymph osmolarity consequently increased and fluid secretion by 
isolated and ligated salivary glands was abolished [113]. Other examples of biological and 
physiological processes which have been studied in ticks include blood feeding [89,115,124,126±131], 
blood digestion [132,133], iron metabolism [134], reproduction [135,136] and innate immunity [137]. 
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Another interesting application of RNAi in ticks is its use as a tool to screen for tick protective 
antigens which may be suitable anti-tick vaccine candidates [138,139]. In these screens, dsRNA is 
transcribed from individual clones of a cDNA library and screened in increasingly smaller pools for 
their effect on tick feeding and survival. This may result in the identification of proteins that are 
critical for the tick which can subsequently be evaluated as potential vaccine antigens. By using this 
approach, researchers could identify subolesin, a protein which was shown to have efficacy as a 
recombinant antigen in vaccination trials against various tick species, the poultry red mite 
Dermanyssus gallinae, mosquitoes and sand flies [140].  
Silencing of subolesin produces ticks with diminished reproductive performance which prevents 
successful mating and the production of viable offspring. The release of subolesin-silenced ticks,  
alone or in combination with subolesin vaccination, was proposed as an alternative tick control 
strategy [119,141]. Although interesting, many questions concerning the feasibility and consequences 
of this approach, such as the reduced fitness of modified ticks and the ecological impact of their 
release, remain to be answered before this or similar methods can be put into practice.  
Injection of adult female mites or engorged female ticks with dsRNA results in gene silencing  
in their offspring, a phenomenon which is also known as µSDUHQWDO¶ or µWUDQVRYDULDO¶ gene  
silencing [88,106,118]. Parental RNAi may be used to study the function of genes in embryogenesis 
and will facilitate studies in evolutionary developmental biology, an area of tick and mite research 
which lags behind that of many other invertebrates.  
3.3. RNAi to Understand Tick-Pathogen Interactions 
To study tick-pathogen interactions, a typical experimental approach starts with the identification of 
tick genes which are differentially expressed when ticks are infected with a pathogen. Techniques such 
as suppression subtractive hybridization (SSH) [142], two-dimensional (2-D) gel electrophoresis [143], 
2-D fluorescence difference gel electrophoresis (DIGE) [127], RT-PCR [144] and microarrays [145] 
have been used for this purpose. The differential expression is usually confirmed by  
(semi-)quantitative RT-PCR. The expression of genes which are found to be up-regulated following 
infection can subsequently be silenced by RNAi to study the effect of gene knockdown on the course 
of the infection. This approach was for instance followed to identify tick salivary gland proteins  
up-regulated in I. scapularis ticks in response to infection with Borrelia burgdorferi, the causal agent 
of Lyme disease of which I. scapularis is the predominant vector in North America. DIGE coupled 
with mass spectrometric analysis using extracts from B. burgdorferi-infected and uninfected salivary 
glands led to the identification of a histamine release factor (tHRF) which was strongly up-regulated in 
the salivary glands of B. burgdorferi-infected ticks during engorgement. Gene silencing of tHRF in  
B. burgdorferi-infected nymphs impaired successful feeding and resulted in reduced spirochete levels 
in ticks and the mice they had fed upon. It is suggested that the decreased feeding ability of  
tHRF-deficient ticks may have disrupted the B. burgdorferi replication and dissemination inside the 
ticks, reducing the efficiency of spirochete transmission [127]. The laboratory of Erol Fikirg, also 
identified 14 different salivary gland proteins (salp) which are secreted into the host during feeding, by 
probing an I. scapularis salivary gland cDNA expression library with serum from tick-immune  
rabbits [146]. The expression of two of these genes, salp15 and salp16, was found to be selectively 
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increased in I. scapularis ticks infected with B. burgdorferi or A. phagocytophilum,  
respectively [144,147]. Gene silencing of salp15 and salp16 did not impair tick feeding as tHRF did, 
but did interfere with the pathogen life cycle. While the B. burgdorferi levels in the salivary glands of 
control and salp15-deficient ticks were similar, the spirochete burden was significantly lower in the 
mice on which salp15-deficient ticks had fed. This demonstrated that Salp15 facilitates tick-borne  
B. burgdorferi infection in the host [147]. Silencing the gene expression of salp16 inhibited the 
acquisition of A. phagocytophilum by the vector tick from infected mice. Pathogen levels in the gut of 
control and salp16-deficient ticks which had fed on infected mice were similar, but the A. 
phagocytophilum levels in salivary glands were significantly lower in salp16-silenced ticks, suggesting 
that A. phagocytophilum requires salp16 to infect the salivary glands [144]. Other functional analysis 
studies based on RNAi which focused on the tick immune responses have also identified genes which 
may be involved in the vectorial capacity of ticks for a variety of pathogens [114,142,148,149].These 
examples demonstrate the intimate relationships between vector-borne pathogens and their arthropod 
hosts on which RNAi shed light.  
3.4. RNAi in Phthiraptera (Lice) 
Lice are obligate ectoparasites of mammals and birds which may feed on blood (bloodsucking lice 
of the suborder Anoplura) or on skin debris, hairs and feathers (chewing lice). Three Anoplura species 
are ectoparasites of humans: the head louse (Pediculus humanus capitis), the human body louse 
(Pediculus h. humanus) and the crab louse (Phthirus pubis). Of these three, only the body louse is a 
vector of pathogens, including the causal agents of epidemic typhus (Rickettsia prowazekii), trench 
fever (Bartonella quintata) and louseborne relapsing fever (Borrelia recurrentis) [150]. The genome 
of the body louse was recently sequenced and is with 108 Mb the smallest insect genome known to 
date [151]. A gene-specific reduction in transcript levels following the injection of dsRNA in female 
lice was recently reported [152] and key components of the RNAi pathway have also been identified in 
the human body louse genome [150]. Their small genome size, the presence of a functional RNAi 
pathway and differences in their ability to transmit pathogens make the head and body louse 
interesting models for comparative functional genomic studies to unravel the molecular mechanisms 
which determine vector competence [150]. 
4. RNAi of Mosquitoes and Their Associated Pathogens 
Only a few mosquito species are vectors of pathogens that cause serious disease.  
Anopheles gambiae is the primary vector for the malaria parasite Plasmodium falciparum. Aedes 
species are responsible for potentially fatal encephalitis and hemorrhagic fevers caused by Dengue and 
Yellow fever viruses and certain Culex species transmit West Nile virus and nematodes that cause 
filariasis in humans (Table 1). The capacity of mosquitoes to serve as vectors revolves around a 
number of essential behavioral and biological factors, such as their preference for blood-feeding, their 
high susceptibility to parasite infection and their longevity [153]. Some of the most important vector 
species require multiple blood meals during each egg-laying cycle, thereby increasing the risk for 
pathogen transmission [154].  
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4.1. dsRNA Introduction into Mosquitoes 
RNAi-based silencing of gene expression has been achieved in mosquitoes using a number of 
different dsRNA delivery methods. In the majority of studies to date, in vitro synthesized dsRNA have 
been injected directly into the mosquito hemolymph. Those that survive the micro-injection procedure 
are then fed or exposed to the relevant physiological condition and/or stress factors and evaluated for 
the phenotypic effect caused by knockdown of the target gene. In mosquitoes, these often relate to 
effects on certain aspects of fecundity such as oviposition and egg development, or physiological 
evidence of cell damage, insect mortality or behavioral changes (reviewed in [155,156]. The  
micro-injection procedure, however, is not optimal or efficient particularly in light of the PRVTXLWR¶V 
small size. One alternative is to use oral introduction, as demonstrated in a study where chitin 
synthase-targeted dsRNA was fed to An. gambiae larvae, resulting in significant mortality [157]. 
Another is by topical application of dsRNA, demonstrated in Ae. aegypti adults [158]. In a first, Coy et 
al. recently demonstrated that knockdown can be achieved in adult mosquitoes by the oral delivery of 
dsRNA via a liquid sucrose meal. The dsRNA was ingested by adult females and caused a reduction in 
the level of transcription of the vacuolar ATPase gene target [159]. A recombinant densovirus-
mediated RNA interference system has also recently been developed for both in vitro and in vivo  
use [160]. The efficiency of RNAi has been shown to differ between tissue types, with midgut tissues 
and hemocytes being amenable to effective knockdown whereas inhibition of genes in the salivary 
glands required much higher dosages of dsRNA. Nonetheless, the larger quantities appeared to not 
compromise the silencing specificity [161]. Details of the uptake mechanism of exogenously added 
dsRNA and its subsequent processing has not been resolved yet, but processing is thought relate to the 
intrinsic virus-mediated RNAi response of mosquitoes (summarized below and reviewed in [33,162]. 
4.2. RNAi to Understand Mosquito Vector Biology 
Functional studies using RNAi have provided a significant amount of insight into vector biology, 
such as integrated pathways that respond to hormonal and nutritional signals affecting feeding, 
vitellogenesis and egg production [153,163±167]; factors involved in lipid biosynthesis [168], vesicle 
transport between the ER and Golgi [169], steroid metabolism [166,170,171]. A large portion of 
literature also addresses olfaction in mosquitoes that influences aspects of their behavior, such as host 
seeking, feeding, mate selection and location of appropriate breeding sites [172,173]. Erdelyan and 
colleagues (2012) identified two CO2 receptor genes, AaGr1 or AaGr3 that upon knockdown resulted 
in a loss of CO2 sensitivity in Ae. aegypti and Culex pipiens quinquefasciatus mosquitoes, impacting 
host detection. Interruption of the olfactory system could be used to design compounds that disrupt the 
mosquito's ability to find a host, thereby limiting the potential for pathogen transmission [174].  
4.3. RNAi as a Tool for Studying Mosquito Vector-Pathogen Interactions 
Initial studies supporting RNAi-based gene silencing as a suitable tool for understanding the  
vector-pathogen interface in mosquitoes, include Dengue virus (DENV) replication inhibition by 
transfection of an Aedes albopictus cell line using DEN1- and DEN2-specific dsRNAs [175,176] and 
knockdown of the antimicrobial gene defensin by in vivo injection of gene-targeted dsRNA into the 
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thorax of adult Anopheles gambiae [177] . A different approach [178], where dsRNA was expressed in 
situ from a transgene stably integrated into the mosquito genome and designed to transcribe an  
intron-spliced RNAi hairpin loop from an upstream promoter, have also become of great use.  
A myriad of studies have been reported, with most using direct delivery of dsRNA rather than the 
more demanding approach of transgenesis.  
With regard to viral transmission by mosquitoes, the long-standing view that mosquito innate 
immunity likely plays a role in restricting virus replication has been addressed in a number of studies. 
Based on the knowledge of immunity in D. melanogaster, orthologs of genes encoding Dcr2, R2D2 
and Ago2, components of the intrinsic arthropod RNAi pathway, were silenced in a number of 
independent studies. Suppression of the mosquito RNAi defense mechanism resulted in an increase of 
alphavirus- and DENV replication in Aedes aegypti cultures and mosquitoes [27,179] and 2¶Q\RQJ-nyong 
replication in Anopheles gambiae [180]. These and other studies have provided clear evidence that 
RNAi is the major defense mechanism against arbovirus infections [181]. Some evidence has also 
been presented that the RNAi response may be systemic. In cultured Aedes albopictus cells, direct  
cell-to-cell spread of an RNAi signal inhibited the replication of incoming Semliki Forest  
viruses [182]. A similar spreading signal has been observed in vivo in D. melanogaster but the 
mechanism remains to be characterized. Studies have also provided evidence for the production of 
virus-derived piRNAs following arbovirus infection in mosquito cells, suggesting that this pathway 
may be another facet of antiviral defense [183]. It has also been possible to generate DENV2-resistant 
Ae. aegypti mosquitoes by constitutively triggering the RNA interference pathway via long  
DENV-specific dsRNAs transcribed from an integrated transgene. This transgenic approach provided 
heritable resistance to virus replication and transmission across 17 generation [184] before expression 
of the effector gene was then lost for unknown reasons. This encouraging result illustrates the potential 
of anti-pathogen suppression using RNAi, as explained in more detail in section 7. 
Microarray-based transcriptional profiling in combination with RNAi is providing new information 
on immune signals that respond to virus infection. In one such a large-scale study, DENV infection of 
Ae. aegypti mosquitoes resulted in the identification of more than 70 genes putatively associated with 
immune signaling [185]. Knockdown of candidates has shown that both the Toll pathway [185] and 
JAK-STAT pathway [186], conventionally associated with defense against bacteria and fungi, also 
contribute to Ae. aegypti virus responses [187,188]. A recent study by Sim and Dimopolous provided 
evidence that Arboviruses are capable of actively suppressing the immune pathways in cells they 
infect, rather than simply failing to trigger host immunity [189]. When the transcriptome of Ae. aegypti 
cells infected with DENV was analyzed using microarrays, the Toll pathway, as in mosquitoes, was 
activated. In addition, numerous immune signaling molecules and anti-microbial peptides (AMPs) 
were down-regulated. In a similar study, Colpitts et al. also demonstrated down-regulation of four 
cecropins and a defensin in Ae. aegypti mosquitoes infected with respectively DENV, WNV and 
Yellow fever virus [190]. The molecular details of the findings in these studies have yet to be validated 
by functional RNAi studies.  
Finally, mammalian cells infected with DENV undergo apoptosis due to a shutting down of protein 
synthesis in host cells. In mosquito cells, however, apoptosis is mostly inhibited, likely to allow for the 
spreading of viral progeny to neighboring cells while evading host inflammatory responses [191]. 
Chen et al. provided evidence that mosquito cells also have strategies for protecting themselves against 
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stresses induced by virus infection, such as GST that is involved in antioxidant defenses and an 
inhibitor of apoptosis, IAP. When GST was silenced in DENV-infected C6/36 mosquito cells, there 
was a higher rate of apoptosis [192]. Furthermore, silencing of IAP rendered mosquito cells highly 
sensitive to DENV-induced oxidative stress [193].  
There is considerable interest in understanding the molecular and cellular interactions between 
mosquito vectors and protozoan parasites, with many studies focusing on the interaction between  
An. gambiae and Plasmodium species. In the past decade, RNAi approaches have been applied in 
numerous studies to unravel the genetic basis of the PRVTXLWR¶V susceptibility and the immune 
responses elicited by the parasite. A multitude of mosquito genes that respond to Plasmodium infection 
have been identified in recent years as reviewed in a number of papers [194±196]. These include genes 
that may either negatively influence Plasmodium development, i.e. antagonists, or have a beneficial 
effect on parasite development, i.e., agonists. Some of the first An. gambiae genes identified and 
verified by RNAi to encode anti-parasitic factors were TEP1 [197] and LRIM1 [198]. These are  
both pattern recognition receptors (PPRs) of the innate immune system, with TEP1 being a 
complement-like protein and LRIM1 a C-type lectin. RNAi-mediated silencing of TEP1 prevented 
melanization of parasites, a mosquito response to lower parasite load, while silencing of LRIM1 
resulted in a substantial increase in oocyte numbers. APL1, a leucine-rich repeat protein was also 
verified as an antagonist [199]. Knockdown studies have since indicated that LRIM1 and APL1C 
occur as a heterodimer in the mosquito hemolymph that interacts with TEP1 [200,201]. It therefore 
seems as if the LRIM1/ApL1C/TEP1 FRPSOH[¶V function is to target Plasmodium parasites  
for destruction.  
Proteins expressed in the mosquito salivary gland that are involved in parasite invasion have also 
been characterized. A study of Gosh and colleagues demonstrated that interaction between the 
salivary-gland-specific surface protein saglin and the parasite surface protein TRAP 
(Thrombospondin-related anonymous protein) is essential for spoorozoite invasion. In vivo RNAi of 
saglin results in a strong inhibition of salivary gland invasion by parasite [202]. Many antagonists have 
since been discovered and their function analyzed using RNAi-based techniques. Most notably, these 
include the hypervariable PPR AgDscam [203], members of the fibrinogen-related protein family 
(FREP) [204] and the C-type lectin CLSP2 [205]. 
Gene silencing approaches have further shown that An. gambiae expresses proteins that protect 
Plasmodium from its immune defenses, or aid in their transport through membrane barriers.  
The C-type lectins CLT4 and CTLM2A serve as examples of immune system agonists.  
Gene knockdown / RNAi-mediated silencing of these genes results in massive melanization of  
ookinetes [198]. Some examples of mosquito proteins required for Plasmodium midgut and salivary 
gland invasion include AgESP, epithelial serine protease and upstream regulator of cytoskeleton 
remodeling [206], PRS1 (Plasmodium responsive salivary 1), a protein up-regulated in infected 
salivary glands [207], the antibacterial protein lysozyme c-1 [208], and hemolymph lipid transporter, 
ApoII/I [209]. RNAi-mediated silencing of these genes in some way caused a phenotype that validated 
their involvement in aiding Plasmodium invasion, reproduction and/or transmission. Proteins with 
properties like these are obvious candidates that merit further investigation for possible use in future 
anti-malaria strategies. 
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5. RNAi in Triatominae and Trypanosoma cruzi. 
Only three examples of RNAi in Triatominae can be found in the literature to date. In 2006, salivary 
nitrophorin 2 (NP2) was silenced and both anticoagulant and apyrase activity in saliva were affected, 
confirming the role of NP2 in blood coagulation [23]. Insight into embryonic development of 
Rhodnius prolixus was provided by RNAi of the gap-gene Rp-gt, confirming its role in proper head 
and abdomen formation and that the function of gt in hemipterans is more similar to that in dipterans 
than previously anticipated. This will be invaluable for understanding the evolution of patterning in 
insect embryos [210].In the closely related Triatoma brasiliensis, an intestinal thrombin inhibitor 
(brasiliensin) was silenced in nymphs [24,211]. Knockdown reduced both the thrombin inhibitory 
activity and the plasma clotting time in midgut tissue, confirming brasiliensin as a potent  
anti-haemostatic targeting thrombin. In addition, silencing decreased bloodmeal uptake, suggesting 
that anticoagulant activity in the vector midgut influences the amount of blood taken from the host. 
With the commencement of mass sequencing of the salivary glands of triatomines, many novel genes 
of unknown function have been identified and need to be evaluated as possible targets for control. 
With phenotypical analysis, after the introduction of dsRNA by injection or ingestion, it was evident 
that although the relevant machinery has not been elucidated to date, an RNAi pathway is present in R. 
prolixus allowing functional genomic studies. 
Trypanosoma cruzi, the causative agent of South American trypanosomiasis / Chagas Disease, is 
transmitted by R. prolixus and is regarded as a neglected tropical disease affecting millions of people 
in the Americas. In contrast to its close relative, T. brucei (see section 6), T. cruzi lacks an RNAi 
pathway. Hypotheses on this loss of RNAi pathways are well described in a review by Lon-Fye and 
colleagues [212]. A valuable observation that has been made from studying protozoan parasites, such 
as trypanosomes, is that there seems to be a direct relationship between the absence of mobile genetic 
elements and RNAi pathway deficiency. This is thought to be a direct result of the decay and finally 
the loss of function of these elements over an extended evolutionary period. The RNAi pathway 
therefore ceased to offer a selective advantage in these organisms and became lost without apparent 
consequences [1].  
There are however four approaches to study T. cruzi that are noteworthy. Firstly, deep sequencing 
and genome-wide analyses revealed a significant number of short non-coding RNAs of which 79 do 
not show homology to known RNA classes. This study will provide insight into alternative RNA 
pathways in T. cruzi [213]. Secondly, there is research conducted to identify essential components of 
the RNAi pathway in T. brucei and to then transfer these to RNAi-deficient pathogens such as T. cruzi, 
enabling RNAi studies [22]. Thirdly, a recent study by Genovesio and colleagues used RNAi from the 
human host perspective to gain insight into the host-pathogen interface. By means of a genome-wide 
RNAi screen of human genes, they identified receptors as well as genes associated with calcium 
release and the TGF-beta signaling pathways, all involved in T. cruzi parasite entry. This study may 
pave the way towards novel entry-inhibiting drug targets [214]. Lastly, the development of integrative 
and episomal transformation allow for reverse genetic approached to be used, as well as rescue studies 
in T. brucei by means of T. cruzi equivalents [215].  
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6. RNAi in the Tsetse Fly and Trypanosoma brucei 
6.1. RNAi Contributions to Understanding Vector Biology 
Introduction of dsRNA into tsetse flies is done via feeding of flies on dsRNA containing 
bloodmeals or by in vivo injection [216]. To date a vast amount of genes have been silenced in the 
tsetse fly to gain insight into their biological functions and contribution to vector fitness. Some 
examples include silencing of Lipophorin, a lipid transport protein. Silencing of Lipophorin resulted in 
decreased lipid levels, delayed oocyte development and extended larval gestation periods but the 
findings still suggest another carrier lipoprotein to also be required for these processes in the tsetse  
fly [16]. Disruption of a nucleotidase-related protein in the salivary glands reduced anti-thrombotic 
activities by some 50%, confirming that nucleotidases in tsetse flies, similar to other haematophagous 
ectoparasites, constitute a major part of the vector¶V anti-haemostatic machinery [17]. RNAi studies of 
two milk proteins GmmMGP2 and GmmMGP3, which are essential for viviparous reproduction, 
identified only GmmMGP2 as the gene impacting fecundity in tsetse flies. The discrimination power 
of RNAi revealed that only in GmmMGP2 knock-down flies, were ovulation, oocyte accumulation and 
degradation disrupted and fecundity reduced [217,218].  
6.2. RNAi Contributions to Understanding Vector-Pathogen Interactions 
Noteworthy is the number of papers in which RNAi was used successfully to disentangle  
host-pathogen interactions between tsetse flies and the causative agent of African and animal 
trypanosomiasis, T. brucei. In the past five years, the following insights have been gained: (1) Tsetse 
ALBA RNA-binding proteins are involved in trypanosome development in vivo [219]; (2) The EP 
protein is a potent immune-responsive molecule in the tsetse fly capable of reducing T. brucei 
infection in the vector midgut [15,220]; (3) Although 16 small Rab GTPases are present in  
T. brucei, three Rab proteins RabX1-3 are novel and play a role in fly infectivity [221]; (4)The 
bacterial endosymbiont of the tsetse fly, Wigglesworthia glossinidiae, actually protects the vector from 
being invaded by T. brucei. The interaction between the tsetse peptidoglycan recognition proteins, the 
bacteria, the level of anti-microbial peptides in the vector, and the mechanism of action are well 
described [222]. Finally, silencing of transferrin in the fat body tissues of tsetse flies increased  
the number of trypanosome infections, indicating a role for transferrin in protecting tsetse flies  
against infection [15]. 
One paper on understanding the host-vector interactions was published by Caljon and colleagues. In 
this study, tsetse flies were fed on rabbits to obtain anti-sera for subsequent screening of a cDNA 
expression library, resulting in the identification of tsetse antigen 5 (TAg5). In patients with allergic 
reactions to tsetse flies, IgE antibodies against TAg5 were detected, showing that this antigen is 
involved in the host-vector interface. Silencing of TAg5 in tsetse flies confirmed this observation as 
saliva from silenced flies displayed a reduced IgE binding potential. This study has contributed in 
confirming antigen-5 related proteins as functional allergens [223]. 
A standard PubMed search conducted with the terms Trypanosoma brucei and gene silencing or 
RNA interference indicate that 495 papers have been published using RNAi in T. brucei. We suggest 
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reading some of the following reviews addressing new understanding of parasite biology and the 
identification of novel drug targets for parasite control [1,224±226]. 
7. RNAi: From Basic Research to Control Strategies 
7.1. RNAi Contributes to the Identification of Candidate Transgenes  
Transgenesis entails the transformation of vectors with transgenes that impair vector and/or 
pathogen development. This growing field of controlling vector-borne diseases is reviewed  
in [227±229]. Noteworthy is the contributions that RNAi-studies have made to the identification and 
evaluation of genes which are now used as transgenes to impact the mosquito vector-pathogen 
interactions (Table 3). Studies on transgenes affecting vector immune response genes such as Rel 
regulatory molecules (which affect the expression of numerous immune genes) and anti-microbial 
peptide genes such as defensins and cecropins, have pioneered this field [230]. With the growth in 
high-throughput screening studies, it is anticipated that the number of RNAi-discovered transgenes for 
vector-borne diseases will escalate within the next few years.  
Table 3. Mosquito transgenes disrupting mosquito-pathogen interactions. Adapted  
from [227]. 
Vector Species Transgene Pathogen(s) targeted 
Reference for RNAi of the 
transgene 





































An. stephensi SM1 Plasmodium berghei [237] 
Ae. aegypti 30Ka; 30Kb Dengue Virus [238] 
Ae. aegypti Anti-DENV2 Dengue Virus [179,184] 
7.2. Paratransgenesis  
An additional strategy to reduce vector competence for disease transmission, involves genetic 
manipulation of natural endosymbionts of a particular vector species to produce molecules that 
impedes pathogen transmission or survival [239]. As described in this review, RNAi has already 
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provided much insight into vector-pathogen interactions and paratrangenesis is already being used with 
success in vectors listed on VectorBase. This strategy was first described in Rhodnius prolixus, the 
Chagas disease vector, using its endosymbiont, Rhodococcus rhodnii. A gene encoding an 
antimicrobial peptide, cecropin A (which was evaluated using RNAi), was cloned into R. rhodnii that 
was stably expressed and released into the gut lumen, killing the disease causing pathogen T. cruzi 
with limited toxicity to the host tissues. Moreover, the transformed bacteria were stably maintained 
without the need for antibiotic selection and could be successfully transmitted to hosts with  
non-transformed endosymbionts due to the coprophagic habits of reduviids. In later studies, 
functionally active single chain antibody fragments (ScFv) were successfully expressed using a 
modified endosymbiotic Corynebacterium spiecies in the kissing bug, Triatoma infestans, as well as R. 
rhodnii in R. prolixus for control of T. cruzi transmission [239]. 
Other bacterial symbionts that have been successfully transformed and stably transmitted include 
Sodalis glossinidius (from Glossina sp.) and Asia sp. (from Anopheles spp.) [240,241]. Transformed 
Asia was also shown to be paternally transmitted in An. stephensi, providing the possibility of using 
non-hematophagous mosquitoes to spread modified endosymbionts for pathogen transmission  
control [242]. A reduction in vector competence may also be achieved by using genetically modified 
densovirusses in mosquitoes. In this regard, transmission of modified virus has been reported for  
Ae. aegypti and A gambiae, respectively [243,244]. To date, a number of endosymbionts have been 
identified may be used in paratransgenic control of insect-borne diseases from triatomine, tsetse fly 
and mosquito vectors [227]. However, few species have been successfully modified and shown to be 
stably transmitted to non-transformed individuals and their resultant progeny. In theory, genetically 
modified endosymbionts may not only provide researches with an additional tool for fighting disease 
but it can also deliver proteins and enzymes that test functional genetic hypotheses formulated from 
RNAi studies. 
7.3. RNAi Together with Integrated High-Throughput Technologies Pave the Way for the Future in 
Combatting Pathogen and Their Vectors  
The discovery of RNAi, for which Andrew Fire and Craig C. Mello were awarded the Nobel Prize 
in Physiology or Medicine in 2006, has once more demonstrated the importance of basic science in 
understanding molecular and physiological mechanisms. With this revelation the door was opened to 
the development of powerful approaches for investigation of functional genomics in a wide array of 
organisms, including those of importance in human and animal health. In the post genomic era, with a 
vast array of sequence information, RNAi provides a method to functionally annotate and subsequently 
validate the expanding spectrum of putative vaccine and drug targets, this is especially evident in the 
fields of tick and mosquito research. 
RNAi in combination with recently developed technologies, such as high-throughput screening 
provides a platform to investigate proteins of vital importance in pathogen survival, transmission and 
the pathogen-vector-host interface. RNAi together with technologies such as deep sequencing 
revolutionized pathogen and vector research by enabling the comprehensive and refined annotation of 
the genomes of these organisms, leading to better knowledge of their RNA, proteins and metabolite 
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derivatives. This finally provides an integrated systematic molecular biological approach for new 
optimized control strategies against these medical and veterinary important organisms [245]. 
Together with genomic data and RNAi integrated technologies basic biological questions regarding 
vectors and their pathogens are in the process of being elucidated. High-throughput sequencing 
provides an invaluable tool to furthermore investigate the full repertoire of RNAi machinery,  
to identify essential components of the pathway and even perhaps to reveal new classes of small  
silencing RNAs. This knowledge will allow for fundamental improvements in RNAi efficiency in  
RNAi-positive organisms and furthermore permit applied research, as the RNAi machinery can be 
reconstructed in organisms lacking the RNAi pathway, since the proof of concept has been confirmed 
in Saccharomyces cerevisiae [246]. 
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